Puberty Onset

Puberty onset is a fundamental biological process that signifies the transition from childhood to reproductive maturity. This complex developmental stage is characterized by a well-defined sequence of physiological events, including the development of secondary sexual characteristics like breast and genital development, the onset of menstruation (menarche) in females, and the pubertal growth spurt.^[1] The timing of these events can vary significantly, with typical variations of 4–6 years within each sex and approximately 2 years between sexes, with girls generally entering puberty an average of two years earlier than boys.^[1] Studies indicate that pubertal traits are highly heritable, with estimates ranging from 0.8 to 0.9.^[1]

Biological Basis

The timing of puberty onset is influenced by a complex interplay of genetic and environmental factors.^[2] Understanding the underlying biological mechanisms is crucial, particularly given the consistent association between earlier puberty and increased risks for various later-life diseases.^[2] Genetic research on pubertal timing has historically focused more on females, largely due to the ease of accurately recalling age at menarche (AAM) as a clear marker of female sexual development.^[2] Genome-wide association studies (GWAS) have identified over 30 loci associated with AAM in women of European descent, with some also found in African Americans.^[1] In contrast, the genetic underpinnings of male puberty have been less thoroughly explored.^[2] However, recent studies, including a GWAS for recalled age at voice breaking in men, have begun to identify genetic signals related to male pubertal timing.^[2] Research suggests that the overall genetic architecture regulating pubertal initiation shares significant overlap between boys and girls, affecting both early and late manifestations of puberty.^[1]Pathway analyses have revealed expected biological processes, such as steroid hormone biosynthesis, and less anticipated ones, like apoptosis, as enriched pathways involved in pubertal onset.^[1] Specific genetic variants, such as those in LIN28B, have been implicated in the timing of menarche, breast development, pubertal height growth spurt, and adult stature, demonstrating genome-wide significance in combined male and female analyses.^[1] Additionally, some BMI(Body Mass Index) associated alleles show sex-specific effects on pubertal initiation; for example,BMI-increasing loci correlate with advanced female breast development, while some BMI-increasing alleles, such as the A allele at MC4R rs571312 , can be associated with delayed male genital development.^[1]

Clinical Relevance

The timing of puberty has significant clinical implications. Altered pubertal timing is linked to an increased risk for a range of health issues later in life, including metabolic syndrome-related disorders such as obesity, diabetes, and cardiovascular disease.^[1]It is also associated with an elevated risk for hormone-dependent cancers.^[1]Specifically, earlier puberty timing has been consistently connected to higher risks for various cancers, cardiovascular disease, and Type 2 diabetes.^[2]In women, earlier AAM has been associated with higher risks for hormone-sensitive cancers.^[2] Conversely, later puberty timing in males has been genetically associated with a longer lifespan, with studies suggesting approximately nine months longer life per year later puberty.^[2]

Social Importance

Puberty onset represents a critical period in human development, marking the transition to reproductive capability and exerting long-term influences on an individual’s health trajectory.^[1] The timing of puberty can affect cardiometabolic risk factors in adulthood for both males and females.^[1]Understanding the factors that regulate puberty onset provides a window of susceptibility for identifying opportunities for cancer prevention during preadolescence and adolescence.^[1]

Phenotypic Assessment and Recall Limitations

The primary method for assessing male puberty timing, relying on self-reported age at voice breaking, introduces inherent limitations due to its retrospective and binned nature. Participants recalled their age at this milestone and selected from broad, predefined age categories, which were subsequently rescaled.^[2] This recall method is prone to imprecision and potential bias, which can dilute the strength of true genetic associations or introduce noise into the data. While age at menarche (AAM) in females is considered a well-recalled and widely used marker, the accuracy of self-reported pubertal events, particularly in men, can be challenging and may not capture the precise timing of biological onset.^[2] Other studies have highlighted the general challenges associated with the self-assessment of pubertal stages, underscoring the potential for inaccuracies in retrospectively collected data.^{[3], [4], [5]} Furthermore, the study’s approach of combining continuous age at voice breaking data from one cohort with dichotomous puberty timing traits from another using Multi-Trait Analysis of GWAS (MTAG) presents a methodological consideration.^[2] Although MTAG is designed to increase statistical power, merging different types of phenotypic measures, even when aligned, could introduce heterogeneity in the underlying trait definition. While the study performed sensitivity analyses to address potential violations of MTAG’s homogeneity assumptions, the fundamental difference in how these traits were originally captured—as a continuous recalled age versus a binary indicator of pubertal development—could influence the precision with which a continuous biological process like puberty timing is characterized.^[2] Relying predominantly on “age at voice breaking” as a singular proxy for male puberty, despite its correlation with other pubertal milestones, might not fully encapsulate the intricate, multi-stage progression of male sexual maturation.^[2]

Generalizability and Population Specificity

A significant limitation concerning the broader applicability of the findings is the restricted genetic ancestry of the study cohorts. The 23andMe cohort exclusively comprised men of European ancestry.^[2]and the meta-analysis for associated traits like longevity and prostate cancer also primarily drew from populations of European descent.^[2] While this demographic homogeneity helps mitigate issues of population stratification in genetic analyses, it inherently restricts the direct transferability of these genetic insights to individuals of non-European ancestries. The genetic architecture and environmental influences on puberty timing can vary substantially across different global populations, implying that the identified genetic variants might exhibit different frequencies, effect sizes, or even be absent in diverse ethnic groups.

The specific composition of the cohorts, particularly the UK Biobank data integrated into the analysis, also introduces potential cohort-specific biases. For instance, the meta-analysis for longevity incorporated data from various UK Biobank subgroups, including those identified as genomically British, self-reported British, Irish, and other white European descent, alongside Lifegen data.^[2] Although the analyses included principal components to account for population structure.^[2] subtle biases or unique environmental exposures within these predominantly European populations could still influence the observed genetic associations. Consequently, the generalizability of these findings is limited to populations of European descent, highlighting the critical need for replication and further investigation in more ethnically diverse populations to ascertain the universal relevance of these genetic discoveries.

Methodological and Statistical Considerations

Despite achieving a substantial effective sample size of 205,354 men through meta-analysis and MTAG, this figure remains considerably smaller than the sample sizes attained in comparable studies of female puberty timing, which often include around 370,000 participants.^[2]This disparity in sample size for male puberty research inherently limits statistical power, potentially hindering the detection of all relevant genetic signals and contributing to a larger proportion of “missing heritability” for male puberty timing compared to its female counterpart.^[2] Moreover, while MTAG was strategically employed to enhance power, its underlying assumptions, such as the homogeneity of effect sizes across the combined traits, could hypothetically be violated if certain SNPs uniquely influence specific pubertal markers but not others, even though the study addressed this by calculating the upper bound for the false discovery rate.^[2] Further statistical challenges arise in the Mendelian Randomization (MR) analyses, particularly regarding potential sample overlap and the influence of horizontal pleiotropy. The study acknowledged a partial overlap between the samples used for the discovery phase of hair color GWAS and those for puberty timing, necessitating sensitivity analyses with non-overlapping samples to mitigate potential bias.^[2] Additionally, the authors pointed out that horizontal pleiotropy—where genetic variants affect both puberty timing and later-life outcomes through independent pathways—might have been underestimated in their longevity analysis, given the inclusion of the same UK Biobank population in both the exposure and outcome samples.^[2] Such unmeasured or underestimated pleiotropic effects complicate the interpretation of causality between puberty timing and later-life health outcomes, making it difficult to definitively distinguish between a true causal link and widespread pleiotropic influences.^[2]

Variants

Genetic variations play a crucial role in influencing the timing of puberty onset, a complex biological process regulated by numerous genes and environmental factors. Several single nucleotide polymorphisms (SNPs) and their associated genes have been identified as key contributors to variations in pubertal development, impacting traits such as age at menarche in females and voice breaking or genital development in males. These variants often affect gene expression, protein function, or regulatory pathways that are integral to the neuroendocrine cascade initiating puberty.

Among the most significant genetic influences on puberty timing are variants located in or near the LIN28B gene and its antisense counterpart, LIN28B-AS1. The variant rs11156429 , situated in or near LIN28B, has been identified as the most significantly associated variant with male puberty timing in large genome-wide association studies, consistent with its known role in developmental processes in both sexes.^[2] LIN28B is a highly conserved RNA-binding protein that acts as a repressor of microRNA biogenesis, particularly affecting the let-7 family of microRNAs, which are known to regulate cell proliferation and differentiation. Alterations in LIN28B activity, such as those potentially influenced by rs11156429 , can lead to advanced menarche, earlier breast development, and variations in pubertal height growth.^[1] The related variant rs9391253 within LIN28B-AS1, an antisense RNA that can modulate LIN28B expression, also contributes to this regulatory network, highlighting the intricate genetic control over pubertal timing.

Other non-coding RNA genes, such as LINC01505 and the RNU6-546P - LINC01876 locus, also harbor variants like rs9408817 and rs142058842 , respectively, which can influence puberty. Long intergenic non-coding RNAs (lincRNAs) and small nuclear RNAs (snRNAs) are critical regulators of gene expression, affecting processes from chromatin structure to mRNA stability, thereby indirectly impacting developmental timing. Similarly, rs1659127 near MIR193BHG, a host gene for microRNA-193b, suggests a role for microRNA regulation in pubertal onset, as miRNAs fine-tune gene expression by repressing translation or degrading mRNA targets. Variants in protein-coding genes like MKLN1 (Myopalladin) and its antisense MKLN1-AS, represented by rs71578952 , could affect cellular structure and signaling pathways, which are essential for the physiological changes underlying puberty.^[1] The context also highlights MKL2 as a locus for male pubertal development, suggesting a broader involvement of myopalladin-related genes in sexual maturation.^[1] Further genetic diversity affecting puberty timing is seen in genes with broad cellular functions. For instance, rs77578010 in C1orf127 (Chromosome 1 Open Reading Frame 127), a gene whose precise function is still being elucidated, may impact puberty through effects on yet-uncharacterized cellular processes. The variant rs7402990 in HERC2 (HECT And RLD Domain Containing E3 Ubiquitin Protein Ligase 2) is well-known for its role in pigmentation but also has broader functions in cell cycle control and DNA repair, suggesting potential indirect effects on developmental timing. Similarly, rs6589961 in JHY(Juvenile Hormone Inducible),rs2222746 in KANSL1 (KAT8 Regulatory NSL Complex Subunit 1), and rs12203592 in IRF4(Interferon Regulatory Factor 4) represent genes involved in diverse biological processes such as chromatin modification, immune response, and transcriptional regulation. These genes, through their fundamental roles in cellular function and regulation, contribute to the complex genetic architecture underlying the variations observed in puberty onset.^{[1], [2]}

Key Variants

RS ID	Gene	Related Traits
rs11156429 rs9391253	LIN28B-AS1	puberty, height growth attribute BMI-adjusted waist circumference BMI-adjusted waist circumference, physical activity major depressive disorder testosterone
rs1659127	Y_RNA - MIR193BHG	body height age at menarche QT interval puberty onset
rs77578010	C1orf127	puberty onset
rs142058842	RNU6-546P - LINC01876	age at voice drop age at menarche puberty onset
rs71578952	MKLN1, MKLN1-AS	puberty onset
rs9408817	LINC01505	age at voice drop puberty onset
rs7402990	HERC2	puberty onset
rs6589961	JHY	puberty onset
rs2222746	KANSL1	puberty onset
rs12203592	IRF4	Abnormality of skin pigmentation eye color hair color freckles progressive supranuclear palsy

Defining Puberty Onset and its Manifestations

Puberty marks a pivotal biological transition from childhood to reproductive maturity, characterized by a complex and sequential series of developmental events.^[1] This process includes the development of secondary sexual characteristics such as breast development in females and genital development in males, alongside menarche in girls and the pubertal growth spurt in both sexes.^[1]The timing of these events, collectively referred to as puberty onset, exhibits substantial individual variability, with a mean variation of 4–6 years within each sex and approximately 2 years between sexes.^[1] Furthermore, pubertal traits are highly heritable, with estimates ranging from 0.8 to 0.9, indicating a strong genetic influence on timing.^[1]The precise definition of puberty onset is often operationalized through the appearance of these secondary sexual characteristics. For females, key markers include the onset of breast development and the age at menarche (AAM), which is a particularly well-studied and recalled event.^[1] In males, the primary indicators involve genital development, voice breaking, and the appearance of facial hair.^[6]These developmental milestones serve as critical points for assessing an individual’s progression through sexual maturation, with altered timing correlating with risks for metabolic syndrome-related disorders such as obesity and diabetes.^[1]

Standardized Classification and Approaches

The most widely adopted system for classifying pubertal development is the Tanner staging system, which provides standardized criteria based on physical examination of secondary sexual characteristics.^[7] This system utilizes schematic drawings and verbal descriptions to categorize the progression of breast and pubic hair development in females, and genital and pubic hair development in males.^[6]While clinical assessment by trained professionals is the gold standard, self-assessment using similar visual aids and questionnaires has also been employed in research, though its accuracy can vary.^[3]Beyond Tanner staging, other quantitative measures contribute to the assessment of puberty onset. Age at menarche (AAM) is a commonly used retrospective measure in females, often collected via questionnaires.^[1] For males, age at voice breaking (VB), defined as the age when the voice becomes occasionally a lot lower or completely changed, and the age of facial hair appearance are important self-reported markers.^[6] Peak height velocity (PHV), estimated through growth curve analysis, also serves as an indicator of pubertal progression.^[6] These diverse approaches allow for comprehensive assessment, crucial for epidemiological studies where direct physical examinations may be challenging.^[1]

Terminology and Diagnostic Criteria for Pubertal Timing

Terminology surrounding puberty onset includes “pubertal timing” or “sexual maturation,” which refer to the age at which an individual commences and progresses through the sequence of pubertal events.^[1]Deviations from typical timing are classified as “advanced pubertal timing” or “earlier puberty,” and “delayed puberty.” For instance, higher body mass index (BMI) is clearly correlated with advanced pubertal timing in girls.^[1]while in boys, the relationship is more complex, with obesity often associated with earlier puberty but a subset exhibiting delay.^[1] Genetic variants, often termed “adiposity loci,” have been shown to influence both BMI and pubertal timing, particularly AAM.^[1]Diagnostic and research criteria for identifying genetic associations with puberty timing involve statistical thresholds and specific genetic markers. Genome-wide association studies (GWAS) typically use a stringent significance threshold, such as P < 5 × 10−8 or 1.67 × 10−8, to identify significant single nucleotide polymorphism (SNP) associations.^[1] Key genetic loci, including those near LIN28B, CAMTA1, and MKL2, have been robustly associated with pubertal timing in combined male and female analyses.^[1] Other genes like TMEM38B and RORA are also recognized as true puberty loci based on their association with Tanner pubertal stage.^[1] These genetic insights provide objective biomarkers and refine our understanding of the underlying mechanisms regulating puberty.

Biological Background

Puberty marks the complex transition from childhood to reproductive maturity, characterized by a defined sequence of developmental events such as breast and genital development, menarche, and the pubertal growth spurt. The timing of pubertal onset is highly variable, with several years of difference observed within sexes and an average of two years between sexes, with girls typically entering puberty earlier than boys.^{[1], [8]} This critical developmental stage is highly heritable, with estimates reaching up to 0.8–0.9, yet the precise molecular mechanisms underlying this variation remain largely underexplored.^{[1], [9], [10]}

Orchestration by the Hypothalamic-Pituitary-Gonadal Axis

The initiation of puberty is centrally regulated by the activation of the hypothalamic-pituitary-gonadal (HPG) axis, a complex neuroendocrine system involving specific tissues and organs. The hypothalamus releases gonadotropin-releasing hormone (GnRH), which stimulates the pituitary gland to secrete gonadotropins, ultimately leading to steroid hormone biosynthesis in the gonads. Pathway analyses have revealed the involvement of hypothalamus-pituitary pathways, such as the TRH receptor signaling pathway, where TRH from the hypothalamus stimulates the pituitary to release thyroid-stimulating hormone (TSH) and prolactin.^[1] Thyroid hormones are crucial for normal sexual development, highlighting the intricate interplay of various hormonal systems in coordinating pubertal onset.^[1]Beyond direct hormonal signaling, cellular functions like apoptosis, a hallmark of tissue remodeling, are also implicated in the biological processes underlying puberty onset. Apoptosis has been identified as an enriched pathway in multiple analyses, suggesting its role in the structural and functional changes that occur in tissues during maturation.^[1]The overall process involves a cascade of molecular and cellular pathways, including steroid hormone biosynthesis and other hormone biosynthetic processes, which are essential for the development of secondary sex characteristics and overall reproductive maturation.^[1]

Genetic Determinants and Heritability

Pubertal timing is a highly heritable trait, with genetic mechanisms playing a substantial role in its variation. Genome-wide association studies (GWAS) have identified numerous genetic variants associated with pubertal timing, predominantly focusing on age at menarche (AAM) in females, which is a late but accurately recalled manifestation of puberty.^{[1], [6], [11]} While the genetic underpinnings of male pubertal timing have been less explored, research indicates a significant overlap in the molecular mechanisms that regulate pubertal initiation in both sexes.^{[1], [6]} For instance, specific alleles associated with earlier menarche in girls often correlate with earlier sexual development in boys, suggesting a shared genetic architecture.^[1] Key genes and regulatory elements have been linked to pubertal timing. The LIN28B gene, for example, has been implicated in the timing of menarche, breast development, the pubertal height growth spurt, and adult stature.^{[1], [12]} While LIN28B shows a stronger association in females, its involvement underscores its broad regulatory role. Another suggestive locus on chromosome 1, within the CAMTA1 gene, with variants rs1149336 and rs1149332 , has been associated with advanced breast development and decreased growth during puberty.^[1] The genetic architecture also includes genes like POMC(pro-opiomelanocortin), a pituitary pro-peptide, which is cleaved into melanogenic peptides by pro-hormone convertase enzymes PC-1 and PC-2, both linked to AAM in females, suggesting a relationship between pigmentation and puberty timing.^[6]

Metabolic and Cellular Modulators

Metabolic processes, particularly those related to body mass, significantly influence pubertal timing. Body mass index (BMI) alleles have been shown to display sex-specific associations with pubertal initiation. Specifically, BMI-increasing loci are correlated with advanced female breast development and earlier pubertal timing, consistent with epidemiological observations.^{[1], [12], [13]}The relationship between overweight/obesity and pubertal timing in boys is more complex; while some BMI variants are associated with earlier male genital development, specific alleles can robustly display the opposite effect.^[1] For example, the BMI-increasing allele (A) at rs571312 in the MC4R gene has been associated with delayed male genital development, a finding not previously linked to puberty.^[1] Similarly, an allele at rs887912 in the FANCL gene also showed an association with delayed sexual development in boys.^[1]These findings highlight the nuanced genetic architecture underlying the epidemiological observation that a subset of overweight individuals may experience delayed puberty. The intricate interplay between genetic predisposition to body mass and the molecular and cellular pathways governing pubertal onset further emphasizes the multifactorial nature of this developmental process.

Developmental Milestones and Health Implications

Puberty involves a well-defined sequence of developmental events, with early physical signs such as genital enlargement in boys and breast development in girls serving as key indicators of initiation, typically assessed using the Tanner scale.^{[1], [7]} The overlap between genetic variants influencing early manifestations of puberty and later manifestations like age of menarche suggests a strong genetic continuity across the entire pubertal timeline.^[1] This developmental process is not merely a marker of reproductive maturity but also has significant systemic consequences for long-term health.

Altered pubertal timing is consistently correlated with an increased risk for a range of later-life diseases. These pathophysiological processes include metabolic syndrome-related disorders such as obesity, diabetes, and cardiovascular disease, as well as hormone-dependent cancers.^{[1], [14], [15]} Furthermore, studies have substantiated links between earlier puberty timing in men and reduced lifespan, suggesting a causal effect or widespread horizontal pleiotropy where genetic variants influence lifespan through mechanisms separate from pubertal timing.^[6] Understanding the biological mechanisms underlying pubertal timing variation is therefore a critical step towards comprehending and potentially mitigating these associated health risks.

Prognostic Indicator for Long-Term Health

The timing of puberty is a significant prognostic indicator for various health outcomes later in life, impacting disease susceptibility and overall lifespan. Earlier pubertal timing, particularly in males, has been consistently associated with increased risks for a range of adverse health conditions, including several cancers, cardiovascular disease, and Type 2 diabetes.^[6]Understanding the genetic determinants of pubertal onset is crucial for elucidating the biological mechanisms underlying these associations and for predicting individual trajectories of health and disease . These findings underscore the importance of assessing pubertal timing as a potential early-life marker for long-term health risks and as a window for disease prevention . Genotype imputation, often using reference panels like the 1000 Genomes, is a standard practice to infer genetic variants, followed by linear regression models adjusted for population structure using principal components.^[6]For instance, the EGG Consortium, which encompasses cohorts such as the Avon Longitudinal Study of Parents and Children (ALSPAC) and the 1958 British Birth Cohort, has analyzed Tanner breast stage in girls and genital stage in boys as quantitative traits, identifying genetic variants likeLIN28B that are significantly associated with the timing of puberty.^{[1], [12]}These extensive studies reveal that puberty onset is a highly heritable trait, with complex genetic influences contributing to its timing.^{[1], [10]}

Sex-Specific and Cross-Population Variations in Puberty Onset

Population studies consistently highlight significant sex-specific differences in pubertal timing, with girls typically initiating puberty approximately two years earlier than boys.^{[1], [8]} While the underlying molecular mechanisms regulating pubertal initiation largely overlap between sexes, genetic associations can display sex-specific patterns; for example, the association of the LIN28B locus with pubertal timing is more pronounced in females than in males.^[1] Cross-population comparisons are vital for identifying diverse genetic influences, as demonstrated by studies that have explored age at menarche in African-American women, revealing population-specific genetic variants.^[16]Furthermore, the relationship between body mass index (BMI) and pubertal timing is complex and sex-dependent; while BMI-increasing genetic loci correlate with advanced female breast development, their association with male genital development is less straightforward, suggesting the need for further genetic investigation to fully understand this interplay across sexes.^[1]

Epidemiological Associations and Long-term Health Implications

The timing of puberty onset is epidemiologically linked to a wide array of adult health outcomes, underscoring its public health significance.^[14]Studies consistently show that altered pubertal timing is associated with an increased risk for metabolic syndrome-related disorders, including obesity, type 2 diabetes, and various cardiometabolic conditions in both men and women.^{[15], [17]}Early age at menarche, a key indicator of female pubertal timing, has specifically been associated with elevated risks of cardiovascular disease, mortality, and certain cancers.^{[13], [18], [19]} Beyond these health risks, population-level analyses have also indicated a shared genetic basis between male puberty timing and lifespan, suggesting that the genetic pathways influencing pubertal development may also impact longevity.^[6] The strong familial concordance observed for age at menarche further emphasizes the significant genetic and potentially shared environmental factors influencing this critical developmental milestone.^[9]

Frequently Asked Questions About Puberty Onset

These questions address the most important and specific aspects of puberty onset based on current genetic research.

---

1. Why did my sister start puberty earlier than me?

Puberty timing varies a lot, even within families, with girls generally starting about two years earlier than boys. While highly heritable, individual genetic differences and environmental factors also contribute to this natural variation.

2. Will my child start puberty around the same age I did?

There’s a strong genetic component to puberty timing, with estimates suggesting it’s 80-90% heritable. So, it’s quite likely your child’s puberty onset will be similar to yours, but environmental factors also play a role.

3. Does my weight affect when my kids hit puberty?

Yes, your body mass index (BMI) can influence puberty timing. For example, some genetic variations linked to higher BMI are associated with earlier breast development in girls. Conversely, specific BMI-increasing alleles, like the A allele atMC4R rs571312 , can be linked to delayed male genital development.

4. Is it bad if my child starts puberty really early?

Earlier puberty has been consistently linked to higher risks for certain health issues later in life. These can include metabolic syndrome, obesity, diabetes, cardiovascular disease, and hormone-dependent cancers.

5. Could starting puberty later mean I’ll live longer?

For males, studies have shown a genetic association between later puberty timing and a longer lifespan. Research suggests approximately nine months longer life for each year puberty is delayed.

6. How do doctors know exactly when I started puberty?

For males, it’s often based on recalling the age your voice broke, but this can be imprecise due to its retrospective nature. Puberty is a complex, multi-stage process, and a single recalled event might not capture the exact biological onset.

7. Is it easier for girls to know their puberty start time?

Yes, for females, the age at menarche (first menstruation) is considered a very clear and generally well-remembered milestone. This makes it a reliable and widely used marker for tracking female pubertal development.

8. Does my family’s background affect when I start puberty?

Absolutely. The genetic architecture and environmental influences on puberty can differ significantly across various global populations. Much of the current genetic research has focused on people of European ancestry, so findings might vary for other ethnic groups.

9. Can my lifestyle choices affect my child’s puberty timing?

While genetics play a huge role, environmental factors also contribute. For instance, body mass can influence timing, with higher BMI sometimes linked to earlier female development, suggesting that lifestyle factors like diet and activity could have an indirect effect.

10. Why do girls usually start puberty before boys?

On average, girls typically begin puberty about two years earlier than boys. This is a consistent biological difference observed across populations, highlighting distinct developmental timelines between the sexes.

---

This FAQ was automatically generated based on current genetic research and may be updated as new information becomes available.

Disclaimer: This information is for educational purposes only and should not be used as a substitute for professional medical advice. Always consult with a healthcare provider for personalized medical guidance.

References

[1] Cousminer, D. L., et al. “Genome-wide association study of sexual maturation in males and females highlights a role for body mass and menarche loci in male puberty.” Human Molecular Genetics, vol. 23, 2014, pp. 4752–4764.

[2] Hollis, B. “Genomic analysis of male puberty timing highlights shared genetic basis with hair colour and lifespan.” Nature Communications, vol. 11, no. 1, 2020, p. 1536.

[3] Bonat, S. et al. “Self-assessment of pubertal stage in overweight children.” Pediatrics, 2002.

[4] Rollof, L. and Elfving, M. “Evaluation of self-assessment of pubertal maturation in boys and girls using drawings and orchidometer.” J. Pediatr. Endocrinol. Metab., 2012.

[5] Desmangles, J.-C. et al. “Accuracy of pubertal Tanner staging self-reporting.” J. Pediatr. Endocrinol. Metab., 2006.

[6] Hollis, B., et al. “Genomic analysis of male puberty timing highlights shared genetic basis with hair colour and lifespan.” Nature Communications.

[7] Marshall, W. A., and J. M. Tanner. “Variations in pattern of pubertal changes in girls.” Archives of Disease in Childhood, vol. 44, 1969, pp. 291–303.

[8] Palmert, M. R., and P. A. Boepple. “Variation in the timing of puberty: clinical spectrum and genetic investigation.” Journal of Clinical Endocrinology & Metabolism, vol. 86, 2001, pp. 2364–2368.

[9] Morris, D. H., et al. “Familial concordance for age at menarche: analyses from the Breakthrough Generations Study.” Paediatric and Perinatal Epidemiology, vol. 25, 2011, pp. 278–285.

[10] Silventoinen, K. et al. “Genetics of pubertal timing and its associations with relative weight in childhood and adult height: the Swedish Young Male Twins Study.” Pediatrics, 2008.

[11] Must, A. et al. “Recall of early menstrual history and menarcheal body size: after 30 years, how well do women remember?” Am. J. Epidemiol., 2002.

[12] Ong, K. K., et al. “Genetic variation in LIN28B is associated with the timing of puberty.” Nature Genetics, vol. 41, 2009, pp. 729–733.

[13] Day, F. R. et al. “Genomic analyses identify hundreds of variants associated with age at menarche and support a role for puberty timing in cancer risk.” Nat. Genet., 2017.

[14] Golub, M. S., et al. “Public health implications of altered puberty timing.” Pediatrics, vol. 121, 2008, pp. S218–S230.

[15] Prentice, P. and Viner, R.M. “Pubertal timing and adult obesity and cardiometabolic risk in women and men: a systematic review and meta-analysis.” Int. J. Obes., 2013.

[16] Demerath, E.W. et al. “Genome-wide association study of age at menarche in African-American women.” Hum. Mol. Genet., 2013.

[17] Wide´n, E. et al. “Pubertal timing and growth influences cardiometabolic risk factors in adult males and females.” Diabetes Care, 2012.

[18] Elks, C. E. et al. “Age at menarche and type 2 diabetes risk: The EPIC-InterAct study.” Diabetes Care, 2013.

[19] Lakshman, R. et al. “Early age at menarche associated with cardiovascular disease and mortality.” J. Clin. Endocrinol. Metab., 2009.